MAPK13 is a serine/threonine kinase and one of four p38 MAPK isoforms that functions as a critical component of stress-activated signal transduction pathways. As a stress-responsive kinase, MAPK13 is activated by extracellular stimuli including pro-inflammatory cytokines, UV irradiation, and cellular stress, leading to phosphorylation of numerous downstream substrates and transcription factors 1. MAPK13 plays tissue-specific roles in regulating epithelial stem cell growth and differentiation, particularly in respiratory epithelium where it controls structural remodeling after injury 2. Mechanistically, MAPK13 regulates mucus production and airway inflammation through activation of type-2 cytokine-stimulated pathways, with selective MAPK13 inhibition effectively preventing these responses in airway epithelial models and in vivo animal models 3. MAPK13 also acts as a transcriptional regulator, with its expression controlled by factors like SP1 and RNA-binding proteins affecting its stability 4. Clinically, MAPK13 is associated with multiple malignancies. In papillary thyroid cancer, elevated MAPK13 expression correlates with poor prognosis, lymph node metastasis, and epithelial-mesenchymal transition, with MAPK13 promoting cell proliferation and migration while inhibiting apoptosis 5. MAPK13 also contributes to post-viral lung disease, asthma, and COPD pathogenesis 2. As a selective p38 MAPK isoform with distinct tissue expression, MAPK13 represents an emerging therapeutic target for respiratory and malignant diseases 6.